BioPartner Nordic ApS: Financial statements 2019
CVR: 38153188
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
BioPartner Nordic ApS (CVR 38153188) has filed annual accounts for 2019. In 2019, the company reported revenue of DKK 57,824 and a net result of DKK -167,368 compared with DKK 185,320 the year before. That is a decrease of 90.1% compared with the year before. The profit margin was -289.4%. Equity in the 2019 report amounted to DKK -117,856.
- Revenue
- DKK 57,824
- Gross Profit
- DKK -137,368
- Profit/Loss
- DKK -167,368
- Equity
- DKK -117,856
- Total Assets
- DKK 100,777
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | 58K | -137K | -167K | -118K | - |
| 2018 | 587K | 185K | 185K | 50K | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
BioPartner Nordic ApS has published its annual report for 2018. Revenue came to DKK 586,605, and the net result was DKK 185,320.
About BioPartner Nordic ApS
BioPartner Nordic ApS is a Danish company of the type Anpartsselskab based in Hedehusene, founded in 2016. The company is registered under the industry Anden teknisk rådgivning. The management consists of John Holger Schultz. The company is owned by John Holger Schultz. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK -7,778 and a net result of DKK -27,378 compared with DKK -79,721 the year before. Equity in the 2025 report amounted to DKK 22,622.
